Ethanol prevents development of destructive arthritis

Proceedings of the National Academy of Sciences of the United States of America

Volumn 104, Issue 1, 2007, Pages 258-263

  Jonsson, Ing Marie ^a   Verdrengh, Margareta ^a   Brisslert, Mikael ^a   Lindblad, Sofia ^a   Bokarewa, Maria ^a   Islander, Ulrika ^a   Carlsten, Hans ^a   Ohlsson, Claes ^a   Nandakumar, Kutty Selva ^b   Holmdahl, Rikard ^b   Tarkowski, Andrej ^a,c  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b LUND UNIVERSITY   (Sweden)

^c UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

Antibodies; Cytokines; Immunity; Inflammation; Sex hormones

Indexed keywords

ACETALDEHYDE; ALCOHOL; COLLAGEN TYPE 2; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; TESTOSTERONE; TRANSCRIPTION FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CHRONIC ARTHRITIS; CONTROLLED STUDY; DOWN REGULATION; ENVIRONMENTAL FACTOR; EXPOSURE; IMMUNE RESPONSE; LEUKOCYTE MIGRATION; LIVER TOXICITY; METABOLITE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; TESTOSTERONE RELEASE; UPREGULATION;

ANIMALS; ARTHRITIS, EXPERIMENTAL; BONE DENSITY; CELL MOVEMENT; COLLAGEN TYPE II; ETHANOL; IMMUNITY, NATURAL; INTERLEUKIN-10; INTERLEUKIN-6; LEUKOCYTES; MALE; MICE; MICE, INBRED DBA; NF-KAPPA B; TESTOSTERONE; TRANSCRIPTION FACTOR AP-1;

MUS;

EID: 33846033048     PISSN: 00278424     EISSN: None     Source Type: Journal    
DOI: 10.1073/pnas.0608620104     Document Type: Article

References (47)

1. Boe DM, Nelson S, Zhang P, Bagby GJ (2001) J Infect Dis 184:1134-1142.
2. Bernardo J (1991) Hosp Pract 26:195-208.
3. Rosa H, Silverio AO, Perini RF, Arruda CB (2000) Am J Gastroenterol 95:1290-1293.
4. Hutchinson SJ, Bird SM, Goldberg DJ (2005) Clin Gastroenterol Hepatol 3:1150-1159.
5. Cooper CL, Cameron DW (2005) Clin Infect Dis 41(Suppl 1):S105-S109.
6. Adams HG, Jordan C (1984) Med Clin N Am 68:179-200.
7. Corrao G, Bagnardi V, Zambon A, La Vecchia C (2004) Prev Med 38:613-619.
8. Di Castelnuovo A, Rotondo S, Iacoviello L, Donati MB, De Gaetano G (2002) Circulation 105:2836-2844.
9. Djousse L, Ellison RC, Beiser A, Scaramucci A, D'Agostino RB, Wolf PA (2002) Stroke 33:907-912.
10. Bengtsson AA, Rylander L, Hagmar L, Nived O, Sturfelt G (2002) Rheumatology (Oxford) 41:563-571.
11. Hardy CJ, Palmer BP, Muir KR, Sutton AJ, Powell RJ (1998) Ann Rheum Dis 57:451-455.
12. Formica MK, Palmer JR, Rosenberg L, McAlindon TE (2003) J Rheumatol 30:1222-1226.
13. Ghaussy NO, Sibbitt WL, Jr, Qualls CR (2001) J Rheumatol 28:2449-2453.
14. Cerhan JR, Saag KG, Criswell LA, Merlino LA, Mikuls TR (2002) J Rheumatol 29:246-254.
15. Hazes JM, Dijkmans BA, Vandenbroucke JP, de Vries RR, Cats A (1990) Ann Rheum Dis 49:980-982.
16. Voigt LF, Koepsell TD, Nelson JL, Dugowson CE, Daling JR (1994) Epidemiology 5:525-532.
17. Nandakumar KS, Backlund J, Vestberg M, Holmdahl R (2004) Arthritis Res Ther 6:R544-R550.
18. Bylund J, Samuelsson M, Collins LV, Karlsson A (2003) Exp Cell Res 282:70-77.
19. Walsh NC, Gravallese EM (2004) Curr Opin Rheumatol 16:419-427.
20. Zhang H, Meadows GG (2005) J Leukocyte Biol 78:1070-1080.
21. Saeed RW, Varma S, Peng T, Tracey KJ, Sherry B, Metz CN (2004) J Immunol 173:6376-6383.
22. St Leger AS, Cochrane AL, Moore F (1979) Lancet i:1017-1020.
23. Fuchs CS, Stampfer MJ, Colditz GA, Giovannucci EL, Manson JE, Kawachi I, Hunter DJ, Hankinson SE, Hennekens CH, Rosner B (1995) N Engl J Med 332:1245-1250.
24. Ellison RC (1990) Epidemiology 1:337-339.
25. Corrao G, Rubbiati L, Bagnardi V, Zambon A, Poikolainen K (2000) Addiction 95:1505-1523.
26. Skoldstam L, Hagfors L, Johansson G (2003) Ann Rheum Dis 62:208-214.
27. Hagfors L, Nilsson I, Skoldstam L, Johansson G (2005) Nutr Metab (London) 2:26.
28. Berbert AA, Kondo CR, Almendra CL, Matsuo T, Dichi I (2005) Nutrition 21:131-136.
29. Pattison DJ, Symmons DP, Young A (2004) Proc Nutr Soc 63:137-143.
30. Chen Y, Mendoza S, Davis-Gorman G, Cohen Z, Gonzales R, Tuttle H, McDonagh PF, Watson RR (2003) Alcohol Alcohol 38:109-114.
31. Steward A, Bayley DL (1992) Agents Actions 35:268-272.
32. Schmidt M, Kreutz M, Loffler G, Scholmerich J, Straub RH (2000) J Endocrinol 164:161-169.
33. Les Dees W, Hiney JK, Srivastava V (1998) Alcohol Health Res World 22:165-169.
34. Lang CH, Fan J, Lipton BP, Potter BJ, McDonough KH (1998) Alcohol Clin Exp Res 22:823-829.
35. Colao A, De Rosa M, Pivonello R, Balestrieri A, Cappabianca P, Di Sarno A, Rochira V, Carani C, Lombardi G (2002) J Clin Endocrinol Metab 87:4193-4197.
36. Kanis JA, Johansson H, Johnell O, Oden A, De Laet C, Eisman JA, Pols H, Tenenhouse A (2005) Osteoporos Int 16:737-742.
37. Nguyen TV, Eisman JA, Kelly PJ, Sambrook PN (1996) Am J Epidemiol 144:255-263.
38. Jochems C, Islander U, Erlandsson M, Verdrengh M, Ohlsson C, Carlsten H (2005) Arthritis Res Ther 7:R837-R843.
39. Zare F, Magnusson M, Bergstrom T, Brisslert M, Josefsson E, Karlsson A, Tarkowski A (2006) J Leukocyte Biol 79:482-488.
40. Carlsten H, Nilsson L, Tarkowski A (1986) Int Arch Allergy Appl Immunol 81:322-325.
41. Josefsson E, Carlsten H, Tarkowski A (1993) Autoimmunity 14:251-257.
42. Smith NB (1984) Clin Chem 30:1672-1674.
43. Penton Z (1987) Clin Chem 33:2094-2095.
44. Verdrengh M, Jonsson IM, Holmdahl R, Tarkowski A (2003) Inflamm Res 52:341-346.
45. Bremell T, Abdelnour A, Tarkowski A (1992) Infect Immun 60:2976-2985.
46. Abdelnour A, Arvidson S, Bremell T, Rydén C, Tarkowski A (1993) Infect Immun 61:3879-3885.
47. Windahl SH, Vidal O, Andersson G, Gustafsson JA, Ohlsson C (1999)J Clin Invest 104:895-901.